Acquiring Company
Global UAV Technologies Ltd
Acquired Company
Nexus Peptide Sciences
VancouverVancouverAgriculture and FarmingBiotechnologyHealth CareDescription
Global UAV Technologies Ltd. has announced its proposal to acquire Nexus Peptide Sciences Inc., a private biotech firm. Under the terms of a letter of intent, Global UAV intends to purchase all outstanding securities of Nexus. The transaction will result in Nexus becoming a wholly-owned subsidiary of Global UAV. Completion is subject to due diligence and regulatory approvals.
Related People
M&A Insights
Based on deal dataFrequently asked
Who acquired Nexus Peptide Sciences?
Nexus Peptide Sciences was acquired by Global UAV Technologies Ltd, based in Vancouver. The deal was reported on July 27, 2026. Global UAV Technologies Ltd. is a Canadian company specializing in the development and deployment of drone technologies. The company focuses on providing aerial data collection solutions across various industries. Global UAV Technologies Ltd is privately held and operates in Agriculture and Farming.
When did Global UAV Technologies Ltd acquire Nexus Peptide Sciences?
Global UAV Technologies Ltd's acquisition of Nexus Peptide Sciences was reported on July 27, 2026. Global UAV Technologies Ltd. has announced its proposal to acquire Nexus Peptide Sciences Inc., a private biotech firm. Under the terms of a letter of intent, Global UAV intends to purchase all outstanding securities of Nexus. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Nexus Peptide Sciences do?
Nexus Peptide Sciences Inc. is a private biotechnology company focused on developing optimized peptide formulations and delivery systems. It is privately held, operating in Biotechnology, and is based in Vancouver.